SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-17-050275
Filing Date
2017-08-08
Accepted
2017-08-08 16:24:12
Documents
1
Period of Report
2017-08-04

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 1480
  Complete submission text file 0001104659-17-050275.txt   2820
Mailing Address 25 BROADWAY, 9TH FLOOR NEW YORK NY 10004
Business Address 25 BROADWAY, 9TH FLOOR NEW YORK NY 10004 212-203-5072
Axsome Therapeutics, Inc. (Issuer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O LANTHEUS HOLDINGS, INC. 331 TREBLE COVE ROAD NORTH BILLERICA NY 01862
Business Address
Golubieski John (Reporting) CIK: 0001610695 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37635 | Film No.: 171015123